Trial intelligence / Profile preview

Pharmacokinetics of Primaquine and Tafenoquine in Lactating Women

NCT07060404Phase 3Not yet recruiting

Sponsor
Curtin University
Start
Apr 2026
Primary completion
Dec 2026
Modality
Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
Countries
1
01

Overview

A Phase 3 trial of primaquine, tafenoquine in vivax malaria, sponsored by Curtin University. Planned start Apr 2026; status: not yet recruiting.

02

Drugs

primaquinetafenoquine
03

Conditions

vivax malaria

Beyond the preview

Go deeper on NCT07060404.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07060404.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call